Latest Equity Funding News

JPMorgan Global Select Equity Fund reported A$39.1 million in operating profit for the year ended 30 June 2026, with net assets rising to A$578.3 million. The result includes fair value gains and comes with a concentrated portfolio, with 100% of fair value investments tied to the underlying JPMorgan Global Select Equity ETF.

JPMorgan Emerging Markets Research Enhanced Index Equity Fund nearly trebled its net assets in 2026 after attracting $48.5 million of applications and recording a $4.6 million profit. The growth came with a sharp increase in exposure to one underlying emerging markets ETF.

Great Dirt Resources has identified 24 priority manganese targets in New South Wales and confirmed rock-chip grades of up to 51.8% manganese. The exploration progress came alongside a $19.1 million FY2026 loss, largely caused by a non-cash share-based payments expense, while cash rose to $3.81 million.

Viridis Mining and Minerals has secured approval for a R$77.5 million BNDES financing facility, reducing the estimated senior debt still required for its Colossus rare earth project to about US$280 million. The 16-year facility carries an indicative current cost of approximately 4.8% and supports the project’s Brazilian processing and research infrastructure.

Osmond Resources reported a A$7.61 million FY26 loss and warned of a material uncertainty over its ability to continue as a going concern, despite holding A$5.50 million in cash. The company is betting its Spanish Orión project can move from exploration into a resource estimate and scoping study in the coming months.

Sunrise Energy Metals has put its Syerston scandium project on a stronger financial footing, ending FY2026 with A$115.4 million in cash and a conditional US$400 million debt commitment. The project still faces a decisive sequence of tests: final investment approval, binding offtake agreements, financing conditions and construction execution.

Element 25 has signed a binding AU$50 million NAIF facility agreement for its Butcherbird Expansion Project, replacing an earlier funding commitment with a contractual financing framework. The money is not yet available: financial close, first drawdown and other conditions precedent remain outstanding.

OncoSil Medical has secured $5.6 million from its three largest institutional investors to fund commercial launches of its OncoSil device in the United States and Australia. The commitments follow FDA and TGA approvals and would lift pro-forma cash to $12.1 million once completed.

Impact Minerals’ 50%-owned Alluminous project reveals a strong financial case for a staged US high purity alumina plant, projecting a post-tax NPV₈ of A$518 million and a 42.3% IRR under a modular development approach.

Viridis Mining has placed its first major equipment order for the Colossus Rare Earth Project, securing critical-path pressure filtration technology that underpins its 2028 production target.

Peak Processing Limited’s FY26 results reveal a doubling loss from continuing operations to $10 million amid a $4.35 million impairment, offset partially by a $2.5 million profit from discontinued operations. The company completed an operational reset and posted its first positive EBITDA quarter in June 2026.

Viridis Mining and Minerals completes a Definitive Feasibility Study for its Colossus Rare Earth Project, confirming strong economics and project readiness, while securing $120 million in equity funding to advance into execution.